Nanomedicine could reduce dose and cost of treatment for people living with HIV, early trials show...


AVERT | 2017-06-12 13:42 UTC

Initial trials using nanotechnology have shown that people living with HIV could reduce the dose of their medication by up to two-thirds with no loss of effectiveness - which could improve adherence and reduce costs.

By AVERT on 2017-06-12 13:42 UTC
  • Need an account?  
    or